FDA preparing to clear roughly 10 million Johnson & Johnson Covid-19 vaccine doses

The Food and Drug Administration is preparing to clear two batches of Johnson & Johnson Covid-19 vaccines that were produced at the troubled Emergent facility in Baltimore, a source familiar with the plans told CNN.